Sarah Able
- Physiology top 10%
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery 3
-
- Radiopharmaceutical Chemistry and Applications 5
-
- RNA Interference and Gene Delivery 3
- Advanced biosensing and bioanalysis techniques 3
- DNA Repair Mechanisms 2
-
- Cancer, Hypoxia, and Metabolism 4
-
- Radiation Therapy and Dosimetry 3
-
- Nanoplatforms for cancer theranostics 3
- Co-authors
- Katherine A. VallisOle TietzR. ChalkFernando Cortezon‐TamaritBart CornelissenCarolyn NapierVeerle KersemansSidath Katugampola
- Journals
- Journal of Nuclear Medicine (2 papers)Molecular Cancer Therapeutics (1 paper)Nature Chemistry (1 paper)
- Partner nations
- United KingdomUnited StatesNetherlands
In The Last Decade
Sarah Able
22 papers receiving 580 citations
Peers
Comparison fields: 5 of 84
- Physiology 39
- Biomaterials 109
- Radiology, Nuclear Medicine and Imaging 118
- Structural Biology 6
- Molecular Biology 265
Countries citing papers authored by Sarah Able
This map shows the geographic impact of Sarah Able's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Able with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Able more than expected).
Fields of papers citing papers by Sarah Able
This network shows the impact of papers produced by Sarah Able. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Able. The network helps show where Sarah Able may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sarah Able, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2022 | 110 | |
| 3 | 2021 | 32 | |
| 4 | 2021 | 14 | |
| 5 | 2021 | 20 | |
| 6 | 2020 | 13 | |
| 7 | 2019 | 13 | |
| 8 | 2018 | 62 | |
| 9 | 2018 | 26 | |
| 10 | 2017 | 18 | |
| 11 | 2017 | 11 | |
| 12 | 2017 | 3 | |
| 13 | 2014 | 12 | |
| 14 | 2013 | 19 | |
| 15 | Targeting {gamma}H2AX during oncogenesis with Auger electron therapy delays tumor onset | 2013 | 1 |
| 16 | 2012 | 63 | |
| 17 | 2012 | 67 | |
| 18 | 2010 | 43 | |
| 19 | 2009 | 13 | |
| 20 | 2009 | 10 |
About Sarah Able
Sarah Able is a scholar working on Physiology, Radiology, Nuclear Medicine and Imaging and Endocrine and Autonomic Systems, having authored 22 papers that have together received 585 indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (5 papers), Cancer, Hypoxia, and Metabolism (4 papers), RNA Interference and Gene Delivery (3 papers), Advanced biosensing and bioanalysis techniques (3 papers), Nanoparticle-Based Drug Delivery (3 papers), Radiation Therapy and Dosimetry (3 papers), Nanoplatforms for cancer theranostics (3 papers) and DNA Repair Mechanisms (2 papers). The work is most often cited by research in Physiology (39 citations), Biomaterials (109 citations) and Radiology, Nuclear Medicine and Imaging (118 citations). Sarah Able has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Katherine A. Vallis, Ole Tietz, R. Chalk, Fernando Cortezon‐Tamarit, Bart Cornelissen, Carolyn Napier, Veerle Kersemans, Sidath Katugampola, William B. Johnson and Siân E. Harding. Their work appears in journals such as Journal of Nuclear Medicine, Molecular Cancer Therapeutics, Nature Chemistry, Radiotherapy and Oncology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.